Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02688088 |
| Title | A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarah Cannon Research Institute at HealthOne | Denver | Colorado | 80218 | United States | Details | |
| IU Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| University of Kansas Hospital | Fairway | Kansas | 66160 | United States | Details | |
| Mary Crowley Cancer Research Center | Dallas | Texas | 75230 | United States | Details | |
| South Texas Accelerated Research Therapeutics, LCC | San Antonio | Texas | 78229-3307 | United States | Details |